Want to join the conversation?
$HELE said during 1Q17 it successfully tested a direct response television campaign for OxyRub, which is the company's proprietary doctor-branded topical pain reliever featuring a patented oxygenated oil in a soothing pleasant smelling formula. For the first time, the company made OxyRub available in select GMC stores.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.